CORTICO BIOSIM Trademark
Trademark Overview
On Tuesday, August 17, 2021, a trademark application was filed for CORTICO BIOSIM with the United States Patent and Trademark Office. The USPTO has given the CORTICO BIOSIM trademark a serial number of 90887985. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, April 25, 2025. This trademark is owned by Cortico BioSim LLC. The CORTICO BIOSIM trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals, namely, corticotropin compositions for use in diagnostic testing and for treatment of disorders such as endocrine disorders, nervous system diseases, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, opthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, tuberculous meningitis and trichinosis
General Information
| Serial Number | 90887985 |
| Word Mark | CORTICO BIOSIM |
| Filing Date | Tuesday, August 17, 2021 |
| Status | 734 - FIFTH EXTENSION - GRANTED |
| Status Date | Friday, April 25, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 28, 2022 |
Trademark Statements
| Description of Mark | The mark consists of the wording "CORTICO" where the first letter "O" is made up of several blue and light blue overlapping circles, and the remaining letters are in dark blue. Below the letters "CORTI" is a thin horizontal line in dark blue and to the right of the line is the wording "BIOSIM" in dark blue. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark. |
| Goods and Services | Pharmaceuticals, namely, corticotropin compositions for use in diagnostic testing and for treatment of disorders such as endocrine disorders, nervous system diseases, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, opthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, tuberculous meningitis and trichinosis |
| Indication of Colors claimed | The colors blue, light blue and dark blue are claimed as a feature of the mark. |
| NOT AVAILABLE | "CORTICO BIOSIM" |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 1, 0001 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Cortico BioSim LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Albuquerque, NM 87110 |
| Party Name | Cortico BioSim LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Albuquerque, NM 87110 |
Trademark Events
| Event Date | Event Description |
| Wednesday, May 18, 2022 | ASSIGNED TO EXAMINER |
| Friday, August 20, 2021 | NEW APPLICATION ENTERED |
| Wednesday, October 6, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 7, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, May 18, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 18, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, May 18, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 18, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, June 28, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 18, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, May 20, 2022 | ASSIGNED TO LIE |
| Wednesday, June 8, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 28, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, January 30, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 23, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, January 30, 2023 | SOU EXTENSION 1 FILED |
| Monday, January 30, 2023 | SOU EXTENSION 1 GRANTED |
| Wednesday, February 1, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, January 29, 2024 | SOU EXTENSION 3 FILED |
| Monday, January 29, 2024 | SOU EXTENSION 3 GRANTED |
| Friday, July 21, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, July 21, 2023 | SOU EXTENSION 2 FILED |
| Friday, July 21, 2023 | SOU EXTENSION 2 GRANTED |
| Tuesday, July 25, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, January 29, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, January 31, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 23, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, January 27, 2025 | SOU EXTENSION 5 FILED |
| Friday, April 25, 2025 | SOU EXTENSION 5 GRANTED |
| Friday, April 25, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, April 25, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 23, 2024 | SOU EXTENSION 4 GRANTED |
| Tuesday, July 23, 2024 | SOU EXTENSION 4 FILED |
| Wednesday, July 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, January 27, 2025 | SOU TEAS EXTENSION RECEIVED |
